BioSpace News Archive

Sommetrics , Inc., which provides products to treat airway obstruction during sleep and in acute care settings, announced today that its quality management system has been certified to the rigorous ISO 13485:2016 standard. During the audit process required for certification, Sommetrics was also evaluated and found to be in compliance with the standards of the Medical Device Single Audit Program (MDSAP) for Canada. “This is

CBSET Inc., a not-for-profit translational research institute, announced that its partner, CILcare, a leading CRO specializing in hearing disorders, has promoted Dr. Cyrille Sage to Director of CILcare’s U.S. operations.

- With an estimated 1 million people in the United States currently living with Parkinson’s, and approximately 60,000 newly diagnosed annually, resources to educate patients and families are critical - Authored by members of the Foundation’s Patient Council, the new guide provides first-hand reflections and practical strategies to answer common questions on understanding and living with Parkinson’s - Anyone touched by Parkinson’s is encouraged to download the free guide at mi

RxMx Corp., a healthcare company with exceptional technology solutions that monitor patient safety, has won the Patient Engagement Innovation award from the Medtech Breakthrough awards for a patient app developed with pharmaceutical company Roche in the area of multiple sclerosis.

The Bio-Process Systems Alliance (BPSA), the international association of the single-use bio-processing industry, is pleased to announce the release of its new technical guide: 2020 Recommendations for Testing, Evaluation, and Control of Particulates from Single-Use Processing Equipment

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the appointment of Matthew Walsh and Rachel Stahler as Chief Financial Officer and Chief Information Officer, respectively, for Organon & Co., its intended spinoff of its women’s health, legacy brands and biosimilars businesses.

Voltron Therapeutics, Inc. announces today a letter to the shareholders. Dear Voltron Therapeutics shareholders, We hope this letter finds you well during this remarkable time. We would also like to thank for your support of Voltron. The current COVID-19 pandemic is exactly the kind of situation that our VaxCelerate platform was cr

Today, NanoVapor Biotech, a division of NanoVapor Inc., announces a newly formed Executive Advisory team to address innovation in pandemic mitigation using nanotechnology on an industrial scale.

VitaLink Research, a leading multi-therapeutic clinical trial network, has adopted the leading, fully-integrated eSource, eRegulatory and Clinical Trial Management System (CTMS) from Clinical Research IO (CRIO).

Early Alzheimer’s disease poses financial burdens on patients, caregivers and society